- Home
- XNCR vs IART Comparison
XNCR vs IART Comparison
Compare XNCR & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- IART
- Stock Information
- Founded
- XNCR 1997
- IART 1989
- Country
- XNCR United States
- IART United States
- Employees
- XNCR N/A
- IART N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- IART Medical/Dental Instruments
- Sector
- XNCR Health Care
- IART Health Care
- Exchange
- XNCR Nasdaq
- IART Nasdaq
- Market Cap
- XNCR 1.7B
- IART 1.7B
- IPO Year
- XNCR 2013
- IART 1995
- Fundamental
- Price
- XNCR $20.45
- IART $25.12
- Analyst Decision
- XNCR Strong Buy
- IART Sell
- Analyst Count
- XNCR 9
- IART 7
- Target Price
- XNCR $36.33
- IART $24.67
- AVG Volume (30 Days)
- XNCR 766.2K
- IART 537.7K
- Earning Date
- XNCR 02-25-2025
- IART 02-26-2025
- Dividend Yield
- XNCR N/A
- IART N/A
- EPS Growth
- XNCR N/A
- IART N/A
- EPS
- XNCR N/A
- IART N/A
- Revenue
- XNCR $85,164,000.00
- IART $1,564,920,000.00
- Revenue This Year
- XNCR N/A
- IART $6.71
- Revenue Next Year
- XNCR $80.86
- IART $6.20
- P/E Ratio
- XNCR N/A
- IART N/A
- Revenue Growth
- XNCR N/A
- IART 1.45
- 52 Week Low
- XNCR $15.31
- IART $16.81
- 52 Week High
- XNCR $27.24
- IART $45.42
- Technical
- Relative Strength Index (RSI)
- XNCR 38.80
- IART 66.65
- Support Level
- XNCR $19.15
- IART $21.26
- Resistance Level
- XNCR $24.66
- IART $22.52
- Average True Range (ATR)
- XNCR 1.14
- IART 0.95
- MACD
- XNCR -0.37
- IART 0.28
- Stochastic Oscillator
- XNCR 24.96
- IART 95.31
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.